Shire plc (SHPG) Tops Q1 EPS by 16c; Reaffirms FY16 Outlook, Offers Commentary

Go back to Shire plc (SHPG) Tops Q1 EPS by 16c; Reaffirms FY16 Outlook, Offers Commentary

Shire Delivers Strong Q1 2016 Results With Double-digit Growth in Revenue and Non GAAP Earnings Per ADS

April 29, 2016 7:53 AM EDT

 

DUBLIN, April 29, 2016 /PRNewswire/ -- Shire plc ("Shire") (LSE: SHP, NASDAQ: SHPG) announces unaudited results for the three months ended March 31, 2016.

 

Financial Highlights 

Q1 2016 

Growth(1)

Non GAAP CER(1)(2)

Product... More

Baxalta Exceeds Guidance and Delivers Strong Sales and Earnings for First Quarter 2016

April 28, 2016 8:00 AM EDT

Positive momentum continues across broad hematology and immunology portfolio Key pipeline and strategic achievements drive continued growth and unlock value across rare disease portfolio R&D and marketing investments position business for future success

BANNOCKBURN, Ill.--(BUSINESS WIRE)-- Baxalta Incorporated (NYSE: BXLT), a global biopharmaceutical leader dedicated to delivering transformative therapies to patients with orphan diseases and underserved conditions, today reported strong first quarter 2016 financial results.

Baxaltas strong financial performance continues to highlight the... More

Shire to Participate at the Deutsche Bank 41st Annual Health Care Conference

April 27, 2016 10:00 AM EDT

LEXINGTON, Massachusetts, April 27, 2016 /PRNewswire/ --

Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Jeff Poulton, Chief Financial Officer, will present at the Deutsche Bank 41st Annual Health Care Conference in Boston, MA on Wednesday, May 04, 2016, 10:00 am EDT (15:00... More